p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma

Cancer

Volumn 88, Issue 8, 2000, Pages 1814-1819

  Kahlenberg, Morton S ^a   Stoler, Daniel L ^b   Rodriguez Bigas, Miguel A ^b   Weber, Thomas K ^b   Driscoll, Deborah L ^b   Anderson, Garth R ^b   Petrelli, Nicholas J ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Mutations; p53 tumor suppressor gene; Sporadic colorectal carcinoma; Survival

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CARCINOMA; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GENES, P53; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0034655188     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000415)88:8<1814::AID-CNCR9>3.0.CO;2-I     Document Type: Article

References (24)

1. Hollstein M, Sidransky D, Vogelstein B, Harris C. p53 mutations in human cancers. Science 1991;253:49-53.
2. Greenblatt MS, Bennett WP, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-78.
3. Abrahams PJ, Schouten R, van Laar T, Houeling A, Terleth C. Different regulation of p53 stability in UV-irradiated normal and DNA repair deficient human cells. Mutat Res 1995; 336(2):169-80.
4. McIlwarth AJ, Vasey PA, Ross GM, Brown R. Cell cycle arrest and radiosensitivity of human tumor cell line: dependence on wild-type p53 for radiosensitivity. Cancer Res 1994;54: 3718-22.
5. 2/M by p53. Oncogene 1995; 10:109-16.
6. Kastan MB, Canman CE, Leonard CJ. p53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 1995;14:3-15.
7. Tlsty TD. Cell cycle control and genomic instability. Cancer Metastasis Rev 1995;14:1-2.
8. Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 1992;71:923-35.
9. Starzynska T, Bromley M, Marlicz K, Roberts SA, Ucunski M, Stern PL. Accumulation of p53 in relation to long-term prognosis in colorectal carcinoma. Eur J Gastroenterol Hepatol 1997;9:183-6.
10. Soong R, Grieu F, Robbins P, Dix B, Chen D, Parsons R, et al. p53 alterations are associated with improved prognosis in distal colonic carcinomas. Clin Cancer Res 1997;3:1405-11.
11. Caldes T, Iniesta P, Vega FJ, de Juan C, Lopez JA, Diaz-Rubio E, et al. Comparative survival analysis of p53 gene mutations and protein accumulation in colorectal cancer. Oncology 1998;55:249-57.
12. Kressner U, Inganas M, Byding S, Blikstad I, Pahlman L, Glimelius B, et al. Prognostic value of p53 genetic changes in colorectal cancer. J Clin Oncol 1999;17:593-9.
13. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-86.
14. Cox DR. Regression models and life-tables. J R Stat Soc 1972;34:187-220.
15. Kahlenberg MS, Stoler DL, Basik M, Petrelli NJ, Rodriguez-Bigas MA, Anderson GR. p53 tumor suppressor gene status and genomic instability in sporadic colorectal cancers. J Natl Cancer Inst 1996;88:1665-70.
16. Beahrs OS, Henson DE, Hutter RVP, editors. Manual for staging of cancer. 4th edition. Chicago: American Joint Committee on Cancer. Philadelphia: J.B. Lippincott, 1992.
17. Jen J, Kim H, Piantadosi S, Liu ZF, Levitt RC, Sistonen P, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-21.
18. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectum cancer. JAMA 1990;264:1444-50.
19. Fearon ER, Vogelstein B, A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
20. Levine A, Momand J, Finley C. The p53 tumor suppressor gene. Nature 1991;351:453-6.
21. Dix B, Robbins P, Carrello S, Howe A, Iacopetta B. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas. Br J Cancer 1990;70:585-90.
22. Baas I, Mulder J, Offerhaus G, Vogelstein B, Hamilton S. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
23. Volpe C, Rodriguez-Bigas MA, Petrelli NJ. Wide perineal dissection and its effect on local recurrence following potentially curative abdominoperineal resection for rectal adenocarcinoma. Clin Invest 1996;14:1-5.
24. Kressner U, Inganas M, Byding S, Blikstad I, Pahlman M, Glimelius B, et al. Prognostic value of p53 genetic changes in colorectal cancer. J Clin Oncol 1999;17:593-9.